Helen Broadhurst

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

John E. Mazuski, Leanne B. Gasink, J. Armstrong et al. · Clinical Infectious Diseases · 2016 · 376 citations · Full text

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

Luis Paz‐Ares, Alexander I. Spira, David Raben et al. · Annals of Oncology · 2020 · 217 citations · Full text

Pacific Trial, Medicine, Immunology +6

Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme

Gregory G. Stone, Paul Newell, Leanne B. Gasink et al. · Journal of Antimicrobial Chemotherapy · 2018 · 77 citations · Full text

Safety and Efficacy of Ceftazidime–Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial

John S. Bradley, Emmanuel Roilides, Helen Broadhurst et al. · The Pediatric Infectious Disease Journal · 2019 · 68 citations · Full text

Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial

John S. Bradley, Helen Broadhurst, Karen Cheng et al. · The Pediatric Infectious Disease Journal · 2019 · 66 citations · Full text